Exact Mass: 637.2006600000001

Chrymutasin B

Pelargonidin 3-(6-acetylglucoside)-5-glucoside

Pelargonidin 3-glucoside-5-(6-acetylglucoside)

5- [ (6-O-Acetyl-beta-D-glucopyranosyl) oxy ] -3- (beta-D-glucopyranosyloxy) -4,7-dihydroxyflavylium

Cyanidin 3-(4-acetylrutinoside)

Luteolinidin 5-(3-glucoside-2-acetylglucoside)

5,7,3,4-Tetrahydroxyflavylium 5- (3-glucoside-2-acetylglucoside)

Cyanidin-3-(2-acetylrutinoside)

3,5,7,3,4-Pentahydroxyflavylium 3- (2-acetylrutinoside)

C30H25F10NO3 (637.1674659999999)

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D000890 - Anti-Infective Agents > D023303 - Oxazolidinones D009676 - Noxae > D000963 - Antimetabolites C471 - Enzyme Inhibitor

[(2S,4R,6S)-5-(1,3-dioxoisoindol-2-yl)-6-(4-methoxyphenoxy)-4-phenylmethoxy-2-(phenylmethoxymethyl)oxan-3-yl] acetate

C37H35NO9 (637.23117)

2-methyl-4-[[4-[[4-[(3-tolyl)amino]phenyl][4-[(3-tolylimino]-2,5-cyclohexadien-1-ylidene]methyl]phenyl]amino]benzenesulphonic acid

C40H35N3O3S (637.2399)

Apramycin Sulphate Soluble

C21H43N5O15S (637.2476248)

Apramycin sulfate

C21H43N5O15S (637.2476248)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Apramycin sulfate is an aminoglycoside antibiotic produced by Streptomyces murica and used in veterinary medicine.

Luminate

C22H39N9O11S (637.2489624)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor

2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-3-[[4-fluoro-2-methoxy-5-(1-methylethyl)-4-(trifluoromethyl)[1,1-biphenyl]-2-yl]methyl]-4-methyl-, (4S,5R)-

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones D009676 - Noxae > D000963 - Antimetabolites

{4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-phosphono-phenoxy}-acetic acid

C32H36N3O9P (637.2189056)

CMP-N,N-diacetyllegionaminate(2-)

C22H32N5O15P-2 (637.1632452)

CMP-pseudaminate

C22H32N5O15P-2 (637.1632452)

CMP-diacetamido-8-epilegionaminic acid

C22H32N5O15P-2 (637.1632452)

N-feruloyl tyramine 4,4-O-beta-D-diglucoside

N-caffeoyl O-methyltyramine-4,5-O-beta-D-diglucoside

2-[4-[2-Acetamido-3-oxo-3-[[2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]propyl]-2-phosphonophenoxy]acetic acid

C32H36N3O9P (637.2189056)

Cyanidin-3-(2-acetylrutinoside)

C29H33O16+ (637.1768518)

Akt1-IN-1

C31H32FN5O5S2 (637.1828794)

Akt1-IN-1 (compound 5b) is a potent and selective Akt1 inhibitor with an IC50 value of 18.79 nM in MIA Paca-2 cells. Akt1-IN-1 does not exhibit obvious teratogenicity, hepatotoxicity and cardiotoxicity (No Observed Adverse Effect Level > 100 μM). Akt1-IN-1 can be used for researching anticancer[1].

Cyanidin-3-(2'-acetylrutinoside)

Cyanidin 3-(2'-acetylrutinoside)

Cyanidin 3-(4'-acetylrutinoside)

Pelargonidin 3-(6'-acetylglucoside)-5-glucoside

Pelargonidin 3-glucoside-5-(6'-acetylglucoside)

(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

(2s)-2-carboxy-5-{[(2s,3r,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-6-hydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

(2s)-2-carboxy-5-{[(2s,3r,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-6-hydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

[C27H29N2O16]+ (637.1517014)

10-amino-3-({4,5-dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-({4,5-dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

5-{[(2s,3s,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C29H33O16]+ (637.1768518)

2-(1-carboxy-n-{4-[(2s)-2-(carboxyamino)-2-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}-c-hydroxycarbonimidoyl)ethyl]phenyl}formamido)benzoic acid

C31H31N3O12 (637.1907646)

5-{[(2s,3r,4s,5r,6r)-3-(acetyloxy)-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-1λ⁴-chromen-1-ylium

5-{[(2s,3r,4s,5r,6r)-3-(acetyloxy)-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-1λ⁴-chromen-1-ylium

[C29H33O16]+ (637.1768518)

10-amino-3-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-methyl-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-methyl-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

3-{[(2s,3r,4s,5s,6r)-6-({[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5h-chromen-5-yl

4-ethenyl-7-hydroxy-8-methoxy-3-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one